File Date |
Company (Ticker) Business Description |
Industry | Deal Size $(M) |
Underwriter |
---|---|---|---|---|
09/29/23 |
Abivax (ABVX)
Late-stage French biotech developing therapies for chronic i... |
Health Care |
$100 |
Morgan Stanley |
09/29/23 |
Elevai Labs (ELAB)
Makes physician-dispensed skincare products. |
Consumer Staples |
$8 |
Univest Sec. |
09/29/23 |
Kairos Pharma (KAPA)
Phase 2 biotech developing therapies for cancer. |
Health Care |
$10 |
Boustead |
01/01/17 |
Company Name (Ticker)
Business description |
Industry |
$100 |
Underwriter |
01/01/17 |
Company Name (Ticker)
Business description |
Industry |
$100 |
Underwriter |
01/01/17 |
Company Name (Ticker)
Business description |
Industry |
$100 |
Underwriter |